EUVIMEDEUVIMED entdecken
Crossref

Discovery of toll-like receptors 7 (TLR7) antagonists to minimise the risk of COVID infection in rheumatoid arthritis via virtual screening approaches

P. Dakshinesh, C. Selvinthanuja, K. Dharanikumar, T. Boopathiraj, M. Gunaseelan, V. Sanjai, T. Sivakumar, T. Prabha

Journal of Phytonanotechnology and Pharmaceutical Sciences · 2022

DOI: 10.54085/jpps.2022.2.4.3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Phytonanotechnology and Pharmaceutical Sciences, 2022. Verfasst von P. Dakshinesh und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Dakshinesh, P., Selvinthanuja, C., Dharanikumar, K., Boopathiraj, T., Gunaseelan, M., Sanjai, V., Sivakumar, T., & Prabha, T. (2022). Discovery of toll-like receptors 7 (TLR7) antagonists to minimise the risk of COVID infection in rheumatoid arthritis via virtual screening approaches. Journal of Phytonanotechnology and Pharmaceutical Sciences. https://doi.org/10.54085/jpps.2022.2.4.3

Vancouver

Dakshinesh P, Selvinthanuja C, Dharanikumar K, Boopathiraj T, Gunaseelan M, Sanjai V, et al. Discovery of toll-like receptors 7 (TLR7) antagonists to minimise the risk of COVID infection in rheumatoid arthritis via virtual screening approaches. Journal of Phytonanotechnology and Pharmaceutical Sciences. 2022. doi:10.54085/jpps.2022.2.4.3

BibTeX
@article{Dakshinesh2022,
  author = {Dakshinesh, P. and Selvinthanuja, C. and Dharanikumar, K. and Boopathiraj, T. and Gunaseelan, M. and Sanjai, V. and Sivakumar, T. and Prabha, T.},
  title = {Discovery of toll-like receptors 7 (TLR7) antagonists to minimise the risk of COVID infection in rheumatoid arthritis via virtual screening approaches},
  journal = {Journal of Phytonanotechnology and Pharmaceutical Sciences},
  year = {2022},
  doi = {10.54085/jpps.2022.2.4.3}
}
Kostenlos starten →